Sanger Genomics Private Limited - Company Profile

It is a travel and hospitality private limited company based in Mumbai, Maharashtra, India, established in 2015.
2015 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Sanger Genomics Private Limited

Sanger Genomics Private Limited, a active private limited company, was established on 13 June 2015 in Mumbai, Maharashtra, India. Engaging in wellness & healthcare centers within the travel and hospitality sector, it holds CIN: U74120MH2015PTC265522. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.20 M and a paid-up capital of ₹0.20 M.

It upholds a compliant status. Its leadership includes Milind Vipul Doshi (Director), Manisha Vipul Doshi (Director). Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at Floor-9, Plot- 207, Embassy Centre, Jamnalal Bajaj Marg, Nariman Point, Mumbai, Maharashtra, 400021.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74120MH2015PTC265522

  • Registration Number

    265522

  • Incorporation Date

    13 June 2015

  • Authorized Capital

    ₹0.20 M

  • Paid-Up Capital

    ₹0.20 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.20 M
  • Paid Up Capital ₹ 0.20 M
  • Company Age 10 Year, 8 Months
  • Last Filing with ROC 31 Mar 2023
  • Revenue Growth **** -52.66%
  • Profit Growth **** -100.34%
  • Ebitda **** -90.88%
  • Net Worth -0.37%
  • Total Assets -0.74%
Company report

Sanger Genomics Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Sanger Genomics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Sanger Genomics Private Limited?
Current Directors
Name Designation Appointment Date Status
Milind Vipul Doshi Director 13 Jun 2015 Current
Manisha Vipul Doshi Director 13 Jun 2015 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sanger Genomics.

Sanger Genomics Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 52.66% decrease. The company also saw a substantial fall in profitability, with a 100.34% decrease in profit. The company's net worth dipped by a decrease of 0.37%.

Sanger Genomics revenue growth over time
Sanger Genomics profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -52.66%
*******
*******
*******
*******
Revenue from Operations
*******
 -52.67%
*******
*******
*******
*******
Total Assets
*******
 -0.74%
*******
*******
*******
*******
Profit or Loss
*******
 -100.34%
*******
*******
*******
*******
Net Worth
*******
 -0.37%
*******
*******
*******
*******
EBITDA
*******
 -90.88%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sanger Genomics?

In 2019, Sanger Genomics had a promoter holding of 51.00% and a public holding of 49.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Sanger Genomics?

Unlock and access historical data on people associated with Sanger Genomics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sanger Genomics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sanger Genomics's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sanger Genomics
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Sanger Genomics Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Sanger Genomics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai. was documented.

  • Director Appointment

    Progress on Milind Vipul Doshi was appointed as a Director was appointed as a Director on 13 Jun 2015 & has been associated with this company since 10 years 8 months . was documented.

  • Director Appointment

    Progress on Manisha Vipul Doshi was appointed as a Director was appointed as a Director on 13 Jun 2015 & has been associated with this company since 10 years 8 months . was documented.

  • Company Incorporation

    The activity Sanger Genomics Private Limited was registered on 13 Jun 2015 with Roc Mumbai & aged 10 years 8 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Sanger Genomics Private Limited?

The CIN of Sanger Genomics Private Limited is U74120MH2015PTC265522.

Where is Sanger Genomics Private Limited headquartered?

Sanger Genomics Private Limited is headquartered at Floor-9, Plot- 207, Embassy Centre, Jamnalal Bajaj Marg, Nariman Point, Mumbai, Maharashtra, 400021.

When was Sanger Genomics Private Limited incorporated?

Sanger Genomics Private Limited was incorporated on 13 June 2015.

Who are the current directors of Sanger Genomics Private Limited?

The current directors of Sanger Genomics Private Limited are

What is the primary industry of Sanger Genomics Private Limited?

The primary industry of Sanger Genomics Private Limited is Travel And Hospitality.

Is Sanger Genomics Private Limited a listed company?

Sanger Genomics Private Limited is unlisted.

What is the capital structure of Sanger Genomics Private Limited?

The authorized capital of Sanger Genomics Private Limited is ₹0.20 M, and the paid-up capital is ₹0.20 M.

What is the compliance status of Sanger Genomics Private Limited?

The compliance status of Sanger Genomics Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available